News By Tag
News By Place
Herman Rosenman Appointed as Chief Financial Officer of Natera, Inc
Executive search firm SANFORD ROSE ASSOCIATES® – TOFT GROUP is proud to announce another successful placement.
Mr. Rosenman brings a wealth of financial and executive management experience and knowledge to his new role. His background includes broad skill sets in leadership and financial management in pharmaceuticals, manufacturing and healthcare for Fortune 1000 companies and multi-national corporations. For the eleven years from 2001-2012, Mr. Rosenman was SVP of Finance and CFO of Gen-Probe, Inc. (currently, Hologic, Inc.), a molecular diagnostic company. Prior to joining Gen-Probe, Mr. Rosenman was President and CEO of Ultra Acquisition Corp., a retail chain and consumer products manufacturer. In addition, he served as President and CEO of RadNet Management, Inc., a large healthcare provider, and as Executive Vice President and CFO for Rexene Corp., a Fortune 1000 company in the petrochemicals industry. Mr. Rosenman was previously a partner at Coopers & Lybrand (currently, PricewaterhouseCoopers LLP) where he served numerous Fortune 1000 clients, principally in the pharmaceuticals and telecommunications industries. Mr. Rosenman currently serves on the Board of Directors of Oxford Immunotec, Ltd., Vivus, and Medistem, and has also served on the Boards of Directors of ARYx Therapeutics, Discovery Partners International and thereafter Infinity Pharmaceuticals, and Emphasys Medical. Mr. Rosenman received a B.B.A. in finance and accounting from Pace University and an M.B.A. in finance from the Wharton School of the University of Pennsylvania.
Robin Toft, President and CEO of Sanford Rose Associates® – Toft Group said: “We are exceedingly proud to have conducted the executive search for Natera’s new CFO, which resulted in Mr. Rosenman being selected from an impressive field of highly qualified candidates. We congratulate Mr. Rosenman on his new role as Chief Financial Officer and believe he will make an outstanding contribution to the continued commercialization of the company’s prenatal products and services, thereby changing the future of medicine. We look forward to the continued success of both Mr. Rosenman and our valued client, Natera.”
Natera, Inc., (www.natera.com)
Sanford Rose Associates® - Toft Group (www.sanfordrose.com/
Robin Toft, President and CEO, Sanford Rose Associates – Toft Group at (925) 837-5800